MODIFICATION OF THE ELECTROFIT
Abstract
1. Sodium amytal is effective in the management of the resistive and apprehensive patient, and the post convulsive excitement. It can be used to elicit prognostic productions. More patients can be treated during a given time period.
2. Our preliminary studies indicate that sodium amytal can lessen the severity of the ordinary convulsion or practically abolish it.
3. Our therapeutic results in a small group of patients are as good as those who have not received sodium amytal.
4. No fractures of the spine or other bones have been sustained by our patients.
5. Sodium amytal does not cause alarming apnea, nor does it have the other disadvantages of curare.
6. Our results warrant further use and investigation of the pre-convulsive intravenous use of sodium amytal.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
